Literature DB >> 24556026

[To answer rare cancer issues. Geographical analysis of EMS sarcoma cohort in the Rhône-Alpes region].

Yohan Fayet1, Virginie Chasles2, Françoise Ducimetière3, Olivier Collard4, Claire Berger5, Pierre Meeus6, Dominique Ranchère-Vince6, Philippe Thiesse6, Marie-Pierre Sunyach6, Perrine Marec-Bérard6, Lorraine Poncet7, Philippe Cousin6, Jean-Yves Blay6, Isabelle Ray-Coquard3.   

Abstract

Rare cancer issues have not been much explored yet because of their low incidence. That is why epidemiological studies have difficulties in identifying indisputable etiological risk factors. An expert opinion, mainly concentrated in some establishments, is required for these cancers' management. However, on account of the potential remoteness of these therapeutic resources, the patients' way of care remains also unstudied. By means of a geographical analysis of a regional exhaustive cohort of sarcoma, diagnosed in 2006 and 2007 and followed during five years at least, we can make progress on these different issues. Gastro-Intestinal and Stromal Tumors (GIST) occur more frequently in privileged territories while liposarcomas arise in more deprived areas. The association between liposarcomas and areas deprivation is significant (P=0.05). Moreover, pre-operative biopsy and some clinical patient characteristics, age, grade or tumor localization, are associated with an increase in the distance covered by patients for the first-line treatment (p ≤ 0,001). In the scope of an interdisciplinary collaboration, the geographical approach develops some hypothesis for rare cancers research, which must be tested by other larger scale studies.

Entities:  

Keywords:  cancer management; epidemiology; geography; rare cancers; sarcoma

Mesh:

Year:  2014        PMID: 24556026     DOI: 10.1684/bdc.2014.1891

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  3 in total

Review 1.  Small intestinal gastrointestinal stromal tumor in a young adult woman: a case report and review of the literature.

Authors:  Suzana Manxhuka-Kerliu; Vjollca Sahatciu-Meka; Irma Kerliu; Argjira Juniku-Shkololli; Lloreta Kerliu; Mevlyde Kastrati; Vesa Kotorri
Journal:  J Med Case Rep       Date:  2014-09-28

Review 2.  Rare cancers: Challenges & issues.

Authors:  Raveendran K Pillai; K Jayasree
Journal:  Indian J Med Res       Date:  2017-01       Impact factor: 2.375

3.  KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome.

Authors:  Mehdi Brahmi; Laurent Alberti; Armelle Dufresne; Isabelle Ray-Coquard; Philippe Cassier; Pierre Meeus; Anne-Valérie Decouvelaere; Dominique Ranchère-Vince; Jean-Yves Blay
Journal:  BMC Cancer       Date:  2015-10-24       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.